Abstract
p53 protein was detected by immunohistochemistry in 42% of 52 colorectal adenocarcinomas. Positive tumours were significantly more frequent in the distal colon, and demonstrated a higher rate of cell proliferation. No correlation was found with tumour grade, Dukes' stage, presence of DNA aneuploidy or patient survival. The role of p53 in colorectal carcinogenesis is discussed with particular reference to differences between proximal and distal large bowel cancers.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Scott, N., Sagar, P., Stewart, J. et al. p53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br J Cancer 63, 317–319 (1991). https://doi.org/10.1038/bjc.1991.74
Issue Date:
DOI: https://doi.org/10.1038/bjc.1991.74
This article is cited by
-
Identification of target genes in cancer diseases using protein–protein interaction networks
Network Modeling Analysis in Health Informatics and Bioinformatics (2019)
-
Determination of Tumor Heterogeneity in Colorectal Cancers Using Heterogeneity Tissue Microarrays
Pathology & Oncology Research (2015)
-
Inhibition of autophagy and tumor growth in colon cancer by miR-502
Oncogene (2013)
-
The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor
Oncogene (2011)
-
p53 Status and Its Prognostic Role in Extrahepatic Bile Duct Cancer: A Meta-Analysis of Published Studies
Digestive Diseases and Sciences (2011)